Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Puig

Showing results (41-50 of 423) with videos related to

Pageof 43
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2014
Monoclonal gammopathy of undetermined significance (MGUS) in patients with psoriasis may be associated with long-term treatment with efalizumab, but not with anti-TNF-α treatments or ustekinumabE Vilarrasa, L Puig
Annals of Tropical Medicine and Parasitology|December 18, 2003
Leishmania and HIV co-infection: dermatological manifestationsL Puig, R Pradinaud
Medicina Clinica|September 12, 1987
[Panels of phenotyped donors in the HLA system. Current applications]L Puig, R Mazzara
Actas Dermo-Sifiliograficas|September 2, 2017
European Academy of Dermatology and Venereology (EADV) membership is worthwhile for Spanish dermatologistsE Nagore, L Puig
The British Journal of Dermatology|May 16, 2017
Psoriasis: inequality or individualized care?L Puig, P Putrik
Actas Dermo-Sifiliograficas|July 23, 2018
Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol FoamL Puig, G Carretero
Actas Dermo-Sifiliograficas|December 3, 2014
Treatment goals for psoriasis: Should PASI 90 become the standard of care?T Torres, L Puig
Actas Dermo-Sifiliograficas|February 26, 2015
The use of biosimilar drugs in psoriasis: a position paperG Carretero Hernández, L Puig,
Actas Dermo-Sifiliograficas|November 16, 2014
Therapeutic implications of IL-17A blockade in psoriasisL Puig, J M Carrascosa
Actas Dermo-Sifiliograficas|November 16, 2014
IL-17 in psoriasis. The final frontier or just another brick in the wall?J M Carrascosa, L Puig
Pageof 43

Showing results (41-50 of 423) with videos related to

Sort By:
Pageof 43
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2014
Monoclonal gammopathy of undetermined significance (MGUS) in patients with psoriasis may be associated with long-term treatment with efalizumab, but not with anti-TNF-α treatments or ustekinumabE Vilarrasa, L Puig
Annals of Tropical Medicine and Parasitology|December 18, 2003
Leishmania and HIV co-infection: dermatological manifestationsL Puig, R Pradinaud
Medicina Clinica|September 12, 1987
[Panels of phenotyped donors in the HLA system. Current applications]L Puig, R Mazzara
Actas Dermo-Sifiliograficas|September 2, 2017
European Academy of Dermatology and Venereology (EADV) membership is worthwhile for Spanish dermatologistsE Nagore, L Puig
The British Journal of Dermatology|May 16, 2017
Psoriasis: inequality or individualized care?L Puig, P Putrik
Actas Dermo-Sifiliograficas|July 23, 2018
Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol FoamL Puig, G Carretero
Actas Dermo-Sifiliograficas|December 3, 2014
Treatment goals for psoriasis: Should PASI 90 become the standard of care?T Torres, L Puig
Actas Dermo-Sifiliograficas|February 26, 2015
The use of biosimilar drugs in psoriasis: a position paperG Carretero Hernández, L Puig,
Actas Dermo-Sifiliograficas|November 16, 2014
Therapeutic implications of IL-17A blockade in psoriasisL Puig, J M Carrascosa
Actas Dermo-Sifiliograficas|November 16, 2014
IL-17 in psoriasis. The final frontier or just another brick in the wall?J M Carrascosa, L Puig
Pageof 43